Annexon Inc. (ANNX) NASDAQ
$4.37 (0.13) (-2.89%)
Market Cap: $415.86M
As of 05/16/24 03:59 PM EDT. Market closed.
Annexon Inc. (ANNX)
NASDAQ
$4.37
(0.13) (-2.89%)
Market Cap: $415.86M
As of 05/16/24 03:59 PM EDT. Market closed.
Add to Portfolio
our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington’s disease and alzheimer’s disease by targeting complement-mediated neurodegeneration ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
86
Address
.
PRICE CHART FOR ANNEXON INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.46
Previous Close
$4.50
Days Range
$4.42 - $5.05
52 week range
$1.57 - $8.40
Volume
1,030,401
Avg. Volume (30 days)
1,896,887
Market Cap
$415.86M
Dividend Yield
-
P/E
-
Shares Outstanding
92,412,866
Open
$4.46
Previous Close
$4.50
Days Range
$4.42 - $5.05
52 week range
$1.57 - $8.40
Volume
1,030,401
Avg. Volume (30 days)
1,896,887
Market Cap
$415.86M
Dividend Yield
-
P/E
-
Shares Outstanding
92,412,866
FINANCIAL STATEMENTS FOR ANNEXON INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ANNEXON INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Carson William H. | Director | May 01, 2024 | Buy | $4.68 | 3,200 | 14,982 | 6,400 | May 03, 2024, 04:15 PM |
| Carson William H. | Director | Apr 08, 2024 | Buy | $6.07 | 3,200 | 19,411 | 3,200 | Apr 10, 2024, 07:17 PM |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Feb 20, 2024 | Sale | $5.53 | 2,593 | 14,339 | 82,058 | Feb 21, 2024, 04:31 PM |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Feb 12, 2024 | Sale | $5.53 | 1,349 | 7,460 | 48,592 | Feb 14, 2024, 07:59 PM |
| Love Douglas | PRESIDENT AND CEO | Feb 12, 2024 | Sale | $5.54 | 5,782 | 32,032 | 196,121 | Feb 14, 2024, 07:56 PM |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Feb 12, 2024 | Sale | $5.54 | 1,809 | 10,022 | 45,651 | Feb 14, 2024, 07:54 PM |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Feb 12, 2024 | Sale | $5.54 | 1,810 | 10,027 | 36,075 | Feb 14, 2024, 07:52 PM |
| Yednock Ted | EVP & Chief Innovation Officer | Dec 27, 2023 | Option Exercise | $1.63 | 21,000 | 34,176 | 58,885 | Jan 23, 2024, 05:00 PM |
| Yednock Ted | EVP & Chief Innovation Officer | Jul 11, 2023 | Sale | $3.84 | 1,057 | 4,055 | 37,885 | Jan 23, 2024, 05:00 PM |
| Yednock Ted | EVP & Chief Innovation Officer | Dec 27, 2023 | Sale | $4.52 | 21,000 | 94,966 | 37,885 | Jan 23, 2024, 05:00 PM |
| Overdorf Michael | EVP & Chief Business Officer | Jul 11, 2023 | Sale | $3.84 | 978 | 3,752 | 45,802 | Jan 23, 2024, 04:58 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Jul 11, 2023 | Sale | $3.84 | 1,057 | 4,055 | 47,460 | Jan 23, 2024, 04:57 PM |
| Yednock Ted | EVP & Chief Innovation Officer | Dec 27, 2023 | Option Exercise | $1.63 | 21,000 | 34,176 | 21,000 | Dec 29, 2023, 04:12 PM |
| Yednock Ted | EVP & Chief Innovation Officer | Dec 27, 2023 | Sale | $4.52 | 21,000 | 94,966 | 0 | Dec 29, 2023, 04:12 PM |
| Satter Muneer A | Director | Dec 26, 2023 | Buy | $2.88 | 350,000 | 1,008,000 | 7,406,024 | Dec 28, 2023, 04:30 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | May 25, 2023 | Buy | $2.13 | 300,000 | 639,720 | 5,701,926 | May 30, 2023, 09:54 PM |
| Love Douglas | President & CEO | Feb 15, 2023 | Sale | $5.87 | 6,571 | 38,564 | 197,646 | Feb 17, 2023, 05:12 PM |
| Overdorf Michael | EVP & Chief Business Officer | Feb 14, 2023 | Sale | $6.30 | 144 | 907 | 27,805 | Feb 15, 2023, 07:00 PM |
| Overdorf Michael | EVP & Chief Business Officer | Feb 13, 2023 | Sale | $6.30 | 1,501 | 9,461 | 27,949 | Feb 15, 2023, 07:00 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Feb 14, 2023 | Sale | $6.30 | 166 | 1,046 | 29,542 | Feb 15, 2023, 06:59 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Feb 13, 2023 | Sale | $6.31 | 1,742 | 10,989 | 29,708 | Feb 15, 2023, 06:59 PM |
| Satter Muneer A | Director | Feb 10, 2023 | Buy | $6.80 | 2,647,058 | 17,999,995 | 7,056,024 | Feb 14, 2023, 04:31 PM |
| Satter Muneer A | Director | Jul 07, 2022 | Buy | $3.84 | 2,453,988 | 9,423,314 | 4,408,966 | Jul 11, 2022, 08:42 PM |
| Love Douglas | President & CEO | Apr 14, 2022 | Buy | $2.45 | 60,000 | 146,814 | 200,942 | Apr 18, 2022, 07:04 PM |
| Love Douglas | President & CEO | Nov 11, 2021 | Option Exercise | $1.54 | 100,942 | 155,503 | 100,942 | Nov 15, 2021, 06:05 PM |
| Love Douglas | President & CEO | Sep 16, 2021 | Option Exercise | $1.41 | 7,500 | 10,572 | 7,500 | Sep 20, 2021, 05:46 PM |
| Love Douglas | President & CEO | Sep 16, 2021 | Sale | $22.05 | 7,500 | 165,341 | 0 | Sep 20, 2021, 05:46 PM |
| Yednock Ted | EVP & Chief Scientific Officer | Sep 13, 2021 | Option Exercise | $1.68 | 16,190 | 27,225 | 16,190 | Sep 15, 2021, 06:35 PM |
| Yednock Ted | EVP & Chief Scientific Officer | Sep 13, 2021 | Sale | $20.00 | 16,190 | 323,860 | 0 | Sep 15, 2021, 06:35 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Sep 13, 2021 | Option Exercise | $7.49 | 3,500 | 26,210 | 5,500 | Sep 15, 2021, 06:35 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Sep 13, 2021 | Sale | $20.01 | 3,500 | 70,034 | 2,000 | Sep 15, 2021, 06:35 PM |
| Yednock Ted | EVP & Chief Scientific Officer | Jun 03, 2021 | Option Exercise | $1.41 | 15,000 | 21,144 | 15,000 | Jun 07, 2021, 04:47 PM |
| Yednock Ted | EVP & Chief Scientific Officer | Jun 03, 2021 | Sale | $21.49 | 15,000 | 322,325 | 2,184 | Jun 07, 2021, 04:47 PM |
| Love Douglas | President & CEO | Mar 31, 2021 | Option Exercise | $1.41 | 7,102 | 10,011 | 7,102 | Apr 02, 2021, 12:31 PM |
| Love Douglas | President & CEO | Apr 01, 2021 | Option Exercise | $1.41 | 500 | 705 | 500 | Apr 02, 2021, 12:31 PM |
| Love Douglas | President & CEO | Apr 01, 2021 | Sale | $28.08 | 500 | 14,041 | 300 | Apr 02, 2021, 12:31 PM |
| Love Douglas | President & CEO | Mar 31, 2021 | Sale | $28.11 | 7,102 | 199,621 | 0 | Apr 02, 2021, 12:31 PM |
| Love Douglas | President & CEO | Mar 30, 2021 | Option Exercise | $1.41 | 3,750 | 5,286 | 3,750 | Mar 31, 2021, 04:04 PM |
| Love Douglas | President & CEO | Mar 29, 2021 | Option Exercise | $1.41 | 3,750 | 5,286 | 3,750 | Mar 31, 2021, 04:04 PM |
| Love Douglas | President & CEO | Mar 30, 2021 | Sale | $24.52 | 3,750 | 91,966 | 1,850 | Mar 31, 2021, 04:04 PM |
| Love Douglas | President & CEO | Mar 29, 2021 | Sale | $25.42 | 3,750 | 95,334 | 900 | Mar 31, 2021, 04:04 PM |
| Yednock Ted | EVP & Chief Scientific Officer | Mar 25, 2021 | Option Exercise | $1.68 | 16,175 | 27,148 | 16,175 | Mar 29, 2021, 05:10 PM |
| Yednock Ted | EVP & Chief Scientific Officer | Mar 25, 2021 | Sale | $28.80 | 16,175 | 465,770 | 5,917 | Mar 29, 2021, 05:10 PM |
| Keswani Sanjay | EVP & Chief Medical Officer | Mar 24, 2021 | Option Exercise | $7.49 | 3,995 | 29,917 | 3,995 | Mar 26, 2021, 05:52 PM |
| Keswani Sanjay | EVP & Chief Medical Officer | Mar 24, 2021 | Sale | $30.17 | 3,995 | 120,512 | 0 | Mar 26, 2021, 05:52 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Mar 23, 2021 | Option Exercise | $7.49 | 5,000 | 37,443 | 7,000 | Mar 25, 2021, 07:31 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Mar 23, 2021 | Sale | $28.44 | 5,000 | 142,176 | 5,600 | Mar 25, 2021, 07:31 PM |
| Clarus Lifesciences III, L.P. | 10% Owner | Jul 28, 2020 | Buy | $17.00 | 200,000 | 3,400,000 | 2,730,635 | Jul 30, 2020, 08:00 PM |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | Jul 28, 2020 | Buy | $17.00 | 400,000 | 6,800,000 | 3,241,628 | Jul 28, 2020, 04:45 PM |
| Lew Jennifer | EVP & Chief Financial Officer | Jul 28, 2020 | Buy | $17.00 | 2,000 | 34,000 | 2,000 | Jul 28, 2020, 04:18 PM |
| Satter Muneer A | Director | Jul 28, 2020 | Buy | $17.00 | 200,000 | 3,400,000 | 1,954,978 | Jul 28, 2020, 04:17 PM |
| Flynn James E | 10% Owner | Jul 28, 2020 | Buy | $17.00 | 350,000 | 5,950,000 | 808,914 | Jul 28, 2020, 12:54 PM |
| Flynn James E | 10% Owner | Jul 28, 2020 | Buy | $17.00 | 350,000 | 5,950,000 | 808,914 | Jul 28, 2020, 12:54 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Carson William H. | Director | 05/01/2024 | 14,982 |
| Carson William H. | Director | 04/08/2024 | 19,411 |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 02/20/2024 | 14,339 |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | 02/12/2024 | 7,460 |
| Love Douglas | PRESIDENT AND CEO | 02/12/2024 | 32,032 |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | 02/12/2024 | 10,022 |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | 02/12/2024 | 10,027 |
| Yednock Ted | EVP & Chief Innovation Officer | 12/27/2023 | 34,176 |
| Yednock Ted | EVP & Chief Innovation Officer | 07/11/2023 | 4,055 |
| Yednock Ted | EVP & Chief Innovation Officer | 12/27/2023 | 94,966 |
| Overdorf Michael | EVP & Chief Business Officer | 07/11/2023 | 3,752 |
| Lew Jennifer | EVP & Chief Financial Officer | 07/11/2023 | 4,055 |
| Yednock Ted | EVP & Chief Innovation Officer | 12/27/2023 | 34,176 |
| Yednock Ted | EVP & Chief Innovation Officer | 12/27/2023 | 94,966 |
| Satter Muneer A | Director | 12/26/2023 | 1,008,000 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 05/25/2023 | 639,720 |
| Love Douglas | President & CEO | 02/15/2023 | 38,564 |
| Overdorf Michael | EVP & Chief Business Officer | 02/14/2023 | 907 |
| Overdorf Michael | EVP & Chief Business Officer | 02/13/2023 | 9,461 |
| Lew Jennifer | EVP & Chief Financial Officer | 02/14/2023 | 1,046 |
| Lew Jennifer | EVP & Chief Financial Officer | 02/13/2023 | 10,989 |
| Satter Muneer A | Director | 02/10/2023 | 17,999,995 |
| Satter Muneer A | Director | 07/07/2022 | 9,423,314 |
| Love Douglas | President & CEO | 04/14/2022 | 146,814 |
| Love Douglas | President & CEO | 11/11/2021 | 155,503 |
| Love Douglas | President & CEO | 09/16/2021 | 10,572 |
| Love Douglas | President & CEO | 09/16/2021 | 165,341 |
| Yednock Ted | EVP & Chief Scientific Officer | 09/13/2021 | 27,225 |
| Yednock Ted | EVP & Chief Scientific Officer | 09/13/2021 | 323,860 |
| Lew Jennifer | EVP & Chief Financial Officer | 09/13/2021 | 26,210 |
| Lew Jennifer | EVP & Chief Financial Officer | 09/13/2021 | 70,034 |
| Yednock Ted | EVP & Chief Scientific Officer | 06/03/2021 | 21,144 |
| Yednock Ted | EVP & Chief Scientific Officer | 06/03/2021 | 322,325 |
| Love Douglas | President & CEO | 03/31/2021 | 10,011 |
| Love Douglas | President & CEO | 04/01/2021 | 705 |
| Love Douglas | President & CEO | 04/01/2021 | 14,041 |
| Love Douglas | President & CEO | 03/31/2021 | 199,621 |
| Love Douglas | President & CEO | 03/30/2021 | 5,286 |
| Love Douglas | President & CEO | 03/29/2021 | 5,286 |
| Love Douglas | President & CEO | 03/30/2021 | 91,966 |
| Love Douglas | President & CEO | 03/29/2021 | 95,334 |
| Yednock Ted | EVP & Chief Scientific Officer | 03/25/2021 | 27,148 |
| Yednock Ted | EVP & Chief Scientific Officer | 03/25/2021 | 465,770 |
| Keswani Sanjay | EVP & Chief Medical Officer | 03/24/2021 | 29,917 |
| Keswani Sanjay | EVP & Chief Medical Officer | 03/24/2021 | 120,512 |
| Lew Jennifer | EVP & Chief Financial Officer | 03/23/2021 | 37,443 |
| Lew Jennifer | EVP & Chief Financial Officer | 03/23/2021 | 142,176 |
| Clarus Lifesciences III, L.P. | 10% Owner | 07/28/2020 | 3,400,000 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 07/28/2020 | 6,800,000 |
| Lew Jennifer | EVP & Chief Financial Officer | 07/28/2020 | 34,000 |
| Satter Muneer A | Director | 07/28/2020 | 3,400,000 |
| Flynn James E | 10% Owner | 07/28/2020 | 5,950,000 |
| Flynn James E | 10% Owner | 07/28/2020 | 5,950,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ANNEXON INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 5,043,530 | 0.00084% | 51.98% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,319,975 | 0.06% | -13.6% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,429,486 | 0.00095% | 55% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 248,277 | 0.13% | -64.17% | Value |
| RENAISSANCE TECHNOLOGIES LLC | 671,200 | 0.00756% | 38.62% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 583,913 | 0.07% | No change | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 418,500 (Call) | 0.04% | New | Value |
| D. E. SHAW & CO., INC. | 379,254 | 0.00233% | New | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 258,314 | 0% | No change | Growth |
| AQR CAPITAL MANAGEMENT LLC | 11,378 | 0.00014% | New | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 10,107 | 0.00009% | Exited | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR ANNEXON INC
STOCK BUYBACKS FOR ANNEXON INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
78.69%
6Q
BUYBACK ANNOUNCEMENT(S) FOR ANNEXON INC
LOADING...